@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q63316836 rdfs:label "A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon"@en ;
    schema1:dateModified "2026-03-31T15:08:25+00:00"^^xsd:dateTime ;
    schema1:description "تجربة سريرية"@ar,
        "ensayu clínicu"@ast,
        "assaig clínic"@ca,
        "clinical trial"@en,
        "clinical trial"@en-ca,
        "clinical trial"@en-gb,
        "clinical trial"@en-us,
        "klinika studo"@eo,
        "ensayo clínico"@es,
        "essai clinique"@fr,
        "ensaio clínico"@gl,
        "կլինիկական փորձարկում"@hy,
        "studio clinico"@it,
        "治験"@ja,
        "임상시험"@ko,
        "klinisch onderzoek"@nl,
        "ensaio clínico"@pt,
        "ensaio clínico"@pt-br,
        "клиническое исследование"@ru,
        "klinické štúdie"@sk,
        "клінічне випробування"@uk,
        "thử nghiệm lâm sàng"@vi,
        "临床试验"@zh,
        "临床试验"@zh-hans,
        "臨床試驗"@zh-hant ;
    schema1:version 2476728603 ;
    wikibase:identifiers 1 ;
    wikibase:sitelinks 0 ;
    wikibase:statements 15 ;
    p:P1132 wds:Q63316836-3DD6B5AE-DF1F-4A14-9134-10F201ED087C ;
    p:P1476 wds:Q63316836-4F785D11-3BC1-4C16-A051-E1BA664C4FE1 ;
    p:P2899 wds:Q63316836-C8E93A74-2E95-471F-B0C4-820AD9E80A0C ;
    p:P3098 wds:Q63316836-18916020-865D-4428-89A3-A0470643BFD8 ;
    p:P31 wds:Q63316836-5C01F39D-E8DF-44EB-BC9D-D0350E62E917 ;
    p:P4135 wds:Q63316836-0B440DEC-1421-41BC-A871-0E61F0E67B79 ;
    p:P4844 wds:Q63316836-1E1F32E6-8129-46D9-B35E-C23DF6D5367B,
        wds:Q63316836-8508E9DE-66B9-4248-93A5-D61A79C91C09 ;
    p:P580 wds:Q63316836-9FB206EA-745E-4E13-BF10-52CC46131BFD ;
    p:P582 wds:Q63316836-70AED1E3-D95F-4D7F-BF35-3B8AD0119FB3 ;
    p:P8363 wds:Q63316836-2AC3238A-281D-48E3-8CF3-BF52CBF5214F ;
    p:P859 wds:Q63316836-1D31745D-C4D6-4B42-8282-6F480063C964 ;
    p:P921 wds:Q63316836-4D861A6A-0051-42DC-A54D-4D3135C7D80B,
        wds:Q63316836-519EC7FA-E9E1-4B2D-B4A9-AB11A605FF6B,
        wds:Q63316836-EFCA8BDA-72BD-451D-9553-4542E931E295 ;
    wdt:P1132 500.0 ;
    wdt:P1476 "An Observational, Multi-Center, Cohort Study Evaluating the Antiviral Efficacy, Safety, and Tolerability in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon-alpha 2a (Pegasys®): TRACES STUDY"@en ;
    wdt:P2899 20.0 ;
    wdt:P3098 "NCT01531166" ;
    wdt:P31 wd:Q30612 ;
    wdt:P4135 65.0 ;
    wdt:P4844 wd:Q20817235,
        wd:Q420056 ;
    wdt:P580 "2011-09-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P582 "2014-08-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P8363 wd:Q818574 ;
    wdt:P859 wd:Q39988 ;
    wdt:P921 wd:Q131742,
        wd:Q157661,
        wd:Q6853 .